|
CALL
|
$4.99 Billion
|
64K
|
Q3 2024
New holding
|
|
|
PUT
|
$644 Million
|
2K
|
Q3 2024
New holding
|
|
|
CALL
|
$644 Million
|
2K
|
Q3 2024
New holding
|
|
|
CALL
|
$615 Million
|
13.1K
|
Q3 2024
New holding
|
|
|
CALL
|
$631 Million
|
12.5K
|
Q3 2024
New holding
|
|
|
CALL
|
$482 Million
|
6.6K
|
Q3 2024
New holding
|
|
|
CALL
|
$464 Million
|
3.9K
|
Q3 2024
New holding
|
|
|
PUT
|
$415 Million
|
14.1K
|
Q3 2024
New holding
|
|
|
CALL
|
$378 Million
|
13.1K
|
Q3 2024
New holding
|
|
|
CALL
|
$383 Million
|
6.9K
|
Q3 2024
New holding
|
|
Avadel Pharmaceuticals PLC
|
CALL
|
$344 Million
|
26.2K
|
Q3 2024
New holding
|
|
|
CALL
|
$298 Million
|
13.1K
|
Q3 2024
New holding
|
|
|
CALL
|
$274 Million
|
4.1K
|
Q3 2024
New holding
|
|
|
PUT
|
$221 Million
|
6.5K
|
Q3 2024
New holding
|
|
|
CALL
|
$173 Million
|
20.3K
|
Q3 2024
New holding
|
|
|
CALL
|
$161 Million
|
26.2K
|
Q3 2024
New holding
|
|
|
PUT
|
$144 Million
|
23.5K
|
Q3 2024
New holding
|
|
|
CALL
|
$123 Million
|
13.1K
|
Q3 2024
New holding
|
|
|
PUT
|
$104 Million
|
2.3K
|
Q3 2024
New holding
|
|
|
CALL
|
$99.6 Million
|
13.1K
|
Q3 2024
New holding
|
|
|
CALL
|
$59.9 Million
|
10.5K
|
Q3 2024
New holding
|
|
|
CALL
|
$20.4 Million
|
20.7K
|
Q3 2024
New holding
|
|